Inhibitory effect of tanshinone IIA on inflammatory response in rheumatoid arthritis through regulating β-arrestin 2
The current study aimed to investigate the inhibitory effect of tanshinone IIA (Tan IIA) on the inflammatory response in patients with rheumatoid arthritis (RA) and explore its mechanism. A total of 50 patients with RA were randomly separated into the control group (15 cases) and the research group...
Gespeichert in:
| Veröffentlicht in: | Experimental and therapeutic medicine 2019-05, Vol.17 (5), p.3299-3306 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 3306 |
|---|---|
| container_issue | 5 |
| container_start_page | 3299 |
| container_title | Experimental and therapeutic medicine |
| container_volume | 17 |
| creator | Tang, Jing Zhou, Siwei Zhou, Fanghua Wen, Xiumei |
| description | The current study aimed to investigate the inhibitory effect of tanshinone IIA (Tan IIA) on the inflammatory response in patients with rheumatoid arthritis (RA) and explore its mechanism. A total of 50 patients with RA were randomly separated into the control group (15 cases) and the research group (35 cases). The tumor necrosis factor (TNF)-α and interleukin (IL)-6 levels in serum were determined, and peripheral blood mononuclear cells (PBMCs) were separated from patients with RA and cultured
. The effects of the β-arrestin 2 small interfering (si)RNA incubation, lipopolysaccharide (LPS) stimulation or Tan IIA incubation on TNF-α and IL-6 levels, and the expression levels of β-arrestin 2, NAD-dependent protein deacetylase sirtuin-1 (SIRT1) and transcription factor p65 (p65) proteins were investigated. Prior to treatment, no significant differences in TNF-α and IL-6 levels in serum of patients with RA were identified between the research and control groups. Following treatment, the TNF-α and IL-6 levels in the serum of patients with RA in the research group were significantly lower compared with those in the research group prior to treatment and those in the control group following treatment (P |
| doi_str_mv | 10.3892/etm.2019.7371 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6447808</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2210253974</sourcerecordid><originalsourceid>FETCH-LOGICAL-c345t-f8f71162c6fb032d1f8be0acd66b4a0476355489b61e0292ab4a537282953f583</originalsourceid><addsrcrecordid>eNpdkc1O3DAUha2qqKCBZbeVpW66yeCf-G-DhFBpR0JiA2vLydgTo8QebKcSr8WD9JlwYIraenPt4-8e3asDwGeM1lQqcm7LtCYIq7WgAn8AJ1go0mCE2cfDHSmJj8FZzg-oHsaxlOwTOKZVlwKxEzBvwuA7X2J6gtY52xcYHSwm5MGHGCzcbC5hDNAHN5ppMq9gsnkfQ7ZVhWmw8yL7LTSpDMkXn2Gtcd4NFdzNoyk-7ODv58ak2lgfkJyCI2fGbM8OdQXur7_fXf1sbm5_bK4ub5qetqw0TjqBMSc9dx2iZIud7Cwy_ZbzrjWoFZwy1krVcWwRUcRUlVFBJFGMOibpCly8-e7nbrLb3oaSzKj3yU8mPelovP73J_hB7-IvzdtWSLQYfDsYpPg41-n15HNvx9EEG-esCcGIMKpEW9Gv_6EPcU6hrvdKSdpyhSvVvFF9ijkn696HwUgvmeqaqV4y1Uumlf_y9wbv9J8E6Qu28J9h</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2210834691</pqid></control><display><type>article</type><title>Inhibitory effect of tanshinone IIA on inflammatory response in rheumatoid arthritis through regulating β-arrestin 2</title><source>PubMed Central</source><creator>Tang, Jing ; Zhou, Siwei ; Zhou, Fanghua ; Wen, Xiumei</creator><creatorcontrib>Tang, Jing ; Zhou, Siwei ; Zhou, Fanghua ; Wen, Xiumei</creatorcontrib><description>The current study aimed to investigate the inhibitory effect of tanshinone IIA (Tan IIA) on the inflammatory response in patients with rheumatoid arthritis (RA) and explore its mechanism. A total of 50 patients with RA were randomly separated into the control group (15 cases) and the research group (35 cases). The tumor necrosis factor (TNF)-α and interleukin (IL)-6 levels in serum were determined, and peripheral blood mononuclear cells (PBMCs) were separated from patients with RA and cultured
. The effects of the β-arrestin 2 small interfering (si)RNA incubation, lipopolysaccharide (LPS) stimulation or Tan IIA incubation on TNF-α and IL-6 levels, and the expression levels of β-arrestin 2, NAD-dependent protein deacetylase sirtuin-1 (SIRT1) and transcription factor p65 (p65) proteins were investigated. Prior to treatment, no significant differences in TNF-α and IL-6 levels in serum of patients with RA were identified between the research and control groups. Following treatment, the TNF-α and IL-6 levels in the serum of patients with RA in the research group were significantly lower compared with those in the research group prior to treatment and those in the control group following treatment (P<0.05). Tan IIA inhibited the LPS-induced secretion of TNF-α and IL-6, upregulated the LPS-inhibited expression of the β-arrestin 2 and SIRT1 proteins, and downregulated the LPS-induced expression of the p65 protein in the PBMCs of patients with RA. The β-arrestin 2 small interfering (si)RNA significantly upregulated the secretion of TNF-α and IL-6, inhibited the expression of the SIRT1 protein and upregulated the expression of the p65 protein in PBMCs of patients with RA. Tan II A effectively increased the weight of rats with rheumatoid arthritis, and reduced the circumference of the left posterior ankle, the posterior plantar metatarsal thickness, and the content of serum TNF-α and IL-6. Tan IIA did not significantly reverse these β-arrestin 2 siRNA-induced changes. Tan IIA inhibited the inflammatory response in PBMCs of patients with RA by upregulating β-arrestin 2 expression.</description><identifier>ISSN: 1792-0981</identifier><identifier>EISSN: 1792-1015</identifier><identifier>DOI: 10.3892/etm.2019.7371</identifier><identifier>PMID: 30988705</identifier><language>eng</language><publisher>Greece: Spandidos Publications UK Ltd</publisher><subject>Age ; Alcohol ; Biological products ; Chemokines ; Cytokines ; Drugs ; Immunology ; Laboratory animals ; Males ; Pharmaceuticals ; Proteins ; Rheumatoid arthritis ; Rodents ; Studies ; Tumor necrosis factor-TNF</subject><ispartof>Experimental and therapeutic medicine, 2019-05, Vol.17 (5), p.3299-3306</ispartof><rights>Copyright Spandidos Publications UK Ltd. 2019</rights><rights>Copyright: © Tang et al. 2019</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c345t-f8f71162c6fb032d1f8be0acd66b4a0476355489b61e0292ab4a537282953f583</citedby><cites>FETCH-LOGICAL-c345t-f8f71162c6fb032d1f8be0acd66b4a0476355489b61e0292ab4a537282953f583</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447808/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447808/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30988705$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tang, Jing</creatorcontrib><creatorcontrib>Zhou, Siwei</creatorcontrib><creatorcontrib>Zhou, Fanghua</creatorcontrib><creatorcontrib>Wen, Xiumei</creatorcontrib><title>Inhibitory effect of tanshinone IIA on inflammatory response in rheumatoid arthritis through regulating β-arrestin 2</title><title>Experimental and therapeutic medicine</title><addtitle>Exp Ther Med</addtitle><description>The current study aimed to investigate the inhibitory effect of tanshinone IIA (Tan IIA) on the inflammatory response in patients with rheumatoid arthritis (RA) and explore its mechanism. A total of 50 patients with RA were randomly separated into the control group (15 cases) and the research group (35 cases). The tumor necrosis factor (TNF)-α and interleukin (IL)-6 levels in serum were determined, and peripheral blood mononuclear cells (PBMCs) were separated from patients with RA and cultured
. The effects of the β-arrestin 2 small interfering (si)RNA incubation, lipopolysaccharide (LPS) stimulation or Tan IIA incubation on TNF-α and IL-6 levels, and the expression levels of β-arrestin 2, NAD-dependent protein deacetylase sirtuin-1 (SIRT1) and transcription factor p65 (p65) proteins were investigated. Prior to treatment, no significant differences in TNF-α and IL-6 levels in serum of patients with RA were identified between the research and control groups. Following treatment, the TNF-α and IL-6 levels in the serum of patients with RA in the research group were significantly lower compared with those in the research group prior to treatment and those in the control group following treatment (P<0.05). Tan IIA inhibited the LPS-induced secretion of TNF-α and IL-6, upregulated the LPS-inhibited expression of the β-arrestin 2 and SIRT1 proteins, and downregulated the LPS-induced expression of the p65 protein in the PBMCs of patients with RA. The β-arrestin 2 small interfering (si)RNA significantly upregulated the secretion of TNF-α and IL-6, inhibited the expression of the SIRT1 protein and upregulated the expression of the p65 protein in PBMCs of patients with RA. Tan II A effectively increased the weight of rats with rheumatoid arthritis, and reduced the circumference of the left posterior ankle, the posterior plantar metatarsal thickness, and the content of serum TNF-α and IL-6. Tan IIA did not significantly reverse these β-arrestin 2 siRNA-induced changes. Tan IIA inhibited the inflammatory response in PBMCs of patients with RA by upregulating β-arrestin 2 expression.</description><subject>Age</subject><subject>Alcohol</subject><subject>Biological products</subject><subject>Chemokines</subject><subject>Cytokines</subject><subject>Drugs</subject><subject>Immunology</subject><subject>Laboratory animals</subject><subject>Males</subject><subject>Pharmaceuticals</subject><subject>Proteins</subject><subject>Rheumatoid arthritis</subject><subject>Rodents</subject><subject>Studies</subject><subject>Tumor necrosis factor-TNF</subject><issn>1792-0981</issn><issn>1792-1015</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpdkc1O3DAUha2qqKCBZbeVpW66yeCf-G-DhFBpR0JiA2vLydgTo8QebKcSr8WD9JlwYIraenPt4-8e3asDwGeM1lQqcm7LtCYIq7WgAn8AJ1go0mCE2cfDHSmJj8FZzg-oHsaxlOwTOKZVlwKxEzBvwuA7X2J6gtY52xcYHSwm5MGHGCzcbC5hDNAHN5ppMq9gsnkfQ7ZVhWmw8yL7LTSpDMkXn2Gtcd4NFdzNoyk-7ODv58ak2lgfkJyCI2fGbM8OdQXur7_fXf1sbm5_bK4ub5qetqw0TjqBMSc9dx2iZIud7Cwy_ZbzrjWoFZwy1krVcWwRUcRUlVFBJFGMOibpCly8-e7nbrLb3oaSzKj3yU8mPelovP73J_hB7-IvzdtWSLQYfDsYpPg41-n15HNvx9EEG-esCcGIMKpEW9Gv_6EPcU6hrvdKSdpyhSvVvFF9ijkn696HwUgvmeqaqV4y1Uumlf_y9wbv9J8E6Qu28J9h</recordid><startdate>20190501</startdate><enddate>20190501</enddate><creator>Tang, Jing</creator><creator>Zhou, Siwei</creator><creator>Zhou, Fanghua</creator><creator>Wen, Xiumei</creator><general>Spandidos Publications UK Ltd</general><general>D.A. Spandidos</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20190501</creationdate><title>Inhibitory effect of tanshinone IIA on inflammatory response in rheumatoid arthritis through regulating β-arrestin 2</title><author>Tang, Jing ; Zhou, Siwei ; Zhou, Fanghua ; Wen, Xiumei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c345t-f8f71162c6fb032d1f8be0acd66b4a0476355489b61e0292ab4a537282953f583</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Age</topic><topic>Alcohol</topic><topic>Biological products</topic><topic>Chemokines</topic><topic>Cytokines</topic><topic>Drugs</topic><topic>Immunology</topic><topic>Laboratory animals</topic><topic>Males</topic><topic>Pharmaceuticals</topic><topic>Proteins</topic><topic>Rheumatoid arthritis</topic><topic>Rodents</topic><topic>Studies</topic><topic>Tumor necrosis factor-TNF</topic><toplevel>online_resources</toplevel><creatorcontrib>Tang, Jing</creatorcontrib><creatorcontrib>Zhou, Siwei</creatorcontrib><creatorcontrib>Zhou, Fanghua</creatorcontrib><creatorcontrib>Wen, Xiumei</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Experimental and therapeutic medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tang, Jing</au><au>Zhou, Siwei</au><au>Zhou, Fanghua</au><au>Wen, Xiumei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhibitory effect of tanshinone IIA on inflammatory response in rheumatoid arthritis through regulating β-arrestin 2</atitle><jtitle>Experimental and therapeutic medicine</jtitle><addtitle>Exp Ther Med</addtitle><date>2019-05-01</date><risdate>2019</risdate><volume>17</volume><issue>5</issue><spage>3299</spage><epage>3306</epage><pages>3299-3306</pages><issn>1792-0981</issn><eissn>1792-1015</eissn><abstract>The current study aimed to investigate the inhibitory effect of tanshinone IIA (Tan IIA) on the inflammatory response in patients with rheumatoid arthritis (RA) and explore its mechanism. A total of 50 patients with RA were randomly separated into the control group (15 cases) and the research group (35 cases). The tumor necrosis factor (TNF)-α and interleukin (IL)-6 levels in serum were determined, and peripheral blood mononuclear cells (PBMCs) were separated from patients with RA and cultured
. The effects of the β-arrestin 2 small interfering (si)RNA incubation, lipopolysaccharide (LPS) stimulation or Tan IIA incubation on TNF-α and IL-6 levels, and the expression levels of β-arrestin 2, NAD-dependent protein deacetylase sirtuin-1 (SIRT1) and transcription factor p65 (p65) proteins were investigated. Prior to treatment, no significant differences in TNF-α and IL-6 levels in serum of patients with RA were identified between the research and control groups. Following treatment, the TNF-α and IL-6 levels in the serum of patients with RA in the research group were significantly lower compared with those in the research group prior to treatment and those in the control group following treatment (P<0.05). Tan IIA inhibited the LPS-induced secretion of TNF-α and IL-6, upregulated the LPS-inhibited expression of the β-arrestin 2 and SIRT1 proteins, and downregulated the LPS-induced expression of the p65 protein in the PBMCs of patients with RA. The β-arrestin 2 small interfering (si)RNA significantly upregulated the secretion of TNF-α and IL-6, inhibited the expression of the SIRT1 protein and upregulated the expression of the p65 protein in PBMCs of patients with RA. Tan II A effectively increased the weight of rats with rheumatoid arthritis, and reduced the circumference of the left posterior ankle, the posterior plantar metatarsal thickness, and the content of serum TNF-α and IL-6. Tan IIA did not significantly reverse these β-arrestin 2 siRNA-induced changes. Tan IIA inhibited the inflammatory response in PBMCs of patients with RA by upregulating β-arrestin 2 expression.</abstract><cop>Greece</cop><pub>Spandidos Publications UK Ltd</pub><pmid>30988705</pmid><doi>10.3892/etm.2019.7371</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1792-0981 |
| ispartof | Experimental and therapeutic medicine, 2019-05, Vol.17 (5), p.3299-3306 |
| issn | 1792-0981 1792-1015 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6447808 |
| source | PubMed Central |
| subjects | Age Alcohol Biological products Chemokines Cytokines Drugs Immunology Laboratory animals Males Pharmaceuticals Proteins Rheumatoid arthritis Rodents Studies Tumor necrosis factor-TNF |
| title | Inhibitory effect of tanshinone IIA on inflammatory response in rheumatoid arthritis through regulating β-arrestin 2 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T17%3A54%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhibitory%20effect%20of%20tanshinone%20IIA%20on%20inflammatory%20response%20in%20rheumatoid%20arthritis%20through%20regulating%20%CE%B2-arrestin%202&rft.jtitle=Experimental%20and%20therapeutic%20medicine&rft.au=Tang,%20Jing&rft.date=2019-05-01&rft.volume=17&rft.issue=5&rft.spage=3299&rft.epage=3306&rft.pages=3299-3306&rft.issn=1792-0981&rft.eissn=1792-1015&rft_id=info:doi/10.3892/etm.2019.7371&rft_dat=%3Cproquest_pubme%3E2210253974%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2210834691&rft_id=info:pmid/30988705&rfr_iscdi=true |